Global Clinical Trials Market Size Study, by Sponsor, by Area, by Phase, and Regional Forecasts 2022-2032

Description

Global Clinical Trials Market is valued at approximately USD 115.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2024-2032. Clinical trials are systematic research studies conducted in human participants to evaluate the safety, efficacy, and effectiveness of medical interventions, including drugs, devices, diagnostics, and treatment protocols. These trials are a crucial part of the drug development process and are designed to gather data on new medical products before they are approved for public use. Clinical trials help determine whether a new treatment is more effective or has fewer side effects than the standard treatment or placebo.

The clinical trials market is experiencing significant growth due to the increasing governmental and private sector funding dedicated to healthcare programs and the development of new treatments. As the public becomes more knowledgeable about diseases, there is a growing willingness among individuals to participate in clinical trials, aiding in the discovery of novel therapeutic solutions. Pharmaceutical companies are extensively investing in clinical trials to introduce new products, while universities are receiving substantial funding for research from patrons interested in medical advancements.

Moreover, the outsourcing of clinical trials to countries like China and India is a growing trend, driven by cost-effectiveness and the availability of a skilled workforce and improved facilities. However, this practice raises ethical concerns regarding the conduct of trials in less-developed nations. Decentralized trials are emerging as a solution to the challenges faced by patients unable to match lab hours or travel to trial locations, offering flexibility by conducting trials in non-traditional places like homes or nearby medical facilities.

The key regions considered for the Global Clinical Trials Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Clinical Trials Market in terms of revenue. The market growth in the region is being attributed to factors including a robust pharmaceutical industry, advanced healthcare infrastructure, and a high level of investment in research and development activities. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by the increasing prevalence of chronic diseases, a large and diverse patient population, and the rising cost-effectiveness of conducting trials in countries like China and India. The region also benefits from improvements in healthcare infrastructure, growing investments from global pharmaceutical companies, and supportive government policies aimed at enhancing clinical research capabilities.

Major market players included in this report are:

Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)
ICON plc
Charles River Laboratories International, Inc.
IQVIA
SYNEOS HEALTH
SGS SA
PAREXEL International Corporation
Wuxi AppTec, Inc.
Chiltern International Ltd (Laboratory Corporation of America)
Eli Lilly and Company
Novo Nordisk A/S
Pfizer
Clinipace (Caidya)
Laboratory Corporation of America Holdings
Firma Clinical Research

The detailed segments and sub-segment of the market are explained below:

By Sponsor:

Industry
Government Organizations
Non-Government Organizations
Others
Associations

By Area:

Oncology
Infectious Diseases
Metabolic Diseases
Cardiovascular Diseases
Neuroscience
Respiratory Diseases
Others

By Phase:

Phase 1
Phase 2
Phase 3
Phase 4

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Clinical Trials Market Executive Summary

1.1. Global Clinical Trials Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Sponsor
- 1.3.2. By Area
- 1.3.3. By Phase
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Clinical Trials Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Clinical Trials Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Funding from Governments and Private Sector
- 3.1.2. Technological Advancements in Clinical Trials
- 3.1.3. Rise in Chronic Diseases
3.2. Market Challenges
- 3.2.1. Ethical Concerns in Outsourced Trials
- 3.2.2. Patient Recruitment and Retention
3.3. Market Opportunities
- 3.3.1. Decentralized Trials
- 3.3.2. Predictive Analytics in Clinical Trials

Chapter 4. Global Clinical Trials Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Trials Market Size & Forecasts by Sponsor 2022-2032

5.1. Segment Dashboard
5.2. Global Clinical Trials Market: Sponsor Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Industry
- 5.2.2. Government Organizations
- 5.2.3. Non-Government Organizations
- 5.2.4. Others
- 5.2.5. Associations

Chapter 6. Global Clinical Trials Market Size & Forecasts by Area 2022-2032

6.1. Segment Dashboard
6.2. Global Clinical Trials Market: Area Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Oncology
- 6.2.2. Infectious Diseases
- 6.2.3. Metabolic Diseases
- 6.2.4. Cardiovascular Diseases
- 6.2.5. Neuroscience
- 6.2.6. Respiratory Diseases
- 6.2.7. Others

Chapter 7. Global Clinical Trials Market Size & Forecasts by Phase 2022-2032

7.1. Segment Dashboard
7.2. Global Clinical Trials Market: Phase Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Phase 1
- 7.2.2. Phase 2
- 7.2.3. Phase 3
- 7.2.4. Phase 4

Chapter 8. Global Clinical Trials Market Size & Forecasts by Region 2022-2032

8.1. North America Clinical Trials Market
- 8.1.1. U.S. Clinical Trials Market
  - 8.1.1.1. Sponsor breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Area breakdown size & forecasts, 2022-2032
  - 8.1.1.3. Phase breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Clinical Trials Market
- 8.1.3. Mexico Clinical Trials Market
8.2. Europe Clinical Trials Market
- 8.2.1. UK Clinical Trials Market
- 8.2.2. Germany Clinical Trials Market
- 8.2.3. France Clinical Trials Market
- 8.2.4. Italy Clinical Trials Market
- 8.2.5. Rest of Europe Clinical Trials Market
8.3. Asia-Pacific Clinical Trials Market
- 8.3.1. China Clinical Trials Market
- 8.3.2. India Clinical Trials Market
- 8.3.3. Japan Clinical Trials Market
- 8.3.4. Australia Clinical Trials Market
- 8.3.5. South Korea Clinical Trials Market
- 8.3.6. Rest of Asia Pacific Clinical Trials Market
8.4. Latin America Clinical Trials Market
- 8.4.1. Brazil Clinical Trials Market
- 8.4.2. Mexico Clinical Trials Market
- 8.4.3. Rest of Latin America Clinical Trials Market
8.5. Middle East & Africa Clinical Trials Market
- 8.5.1. Saudi Arabia Clinical Trials Market
- 8.5.2. South Africa Clinical Trials Market
- 8.5.3. Rest of Middle East & Africa Clinical Trials Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. ICON plc
- 9.3.3. Charles River Laboratories International, Inc.
- 9.3.4. IQVIA
- 9.3.5. SYNEOS HEALTH
- 9.3.6. SGS SA
- 9.3.7. PAREXEL International Corporation
- 9.3.8. Wuxi AppTec, Inc.
- 9.3.9. Chiltern International Ltd (Laboratory Corporation of America)
- 9.3.10. Eli Lilly and Company
- 9.3.11. Novo Nordisk A/S
- 9.3.12. Pfizer
- 9.3.13. Clinipace (Caidya)
- 9.3.14. Laboratory Corporation of America Holdings
- 9.3.15. Firma Clinical Research

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes